Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Macrogenics (NQ: MGNX ) 3.470 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 635 Open 3.470 Bid (Size) 3.260 (5) Ask (Size) 3.600 (1) Prev. Close 3.470 Today's Range 3.470 - 3.470 52wk Range 3.140 - 21.88 Shares Outstanding 61,107,288 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, CrowdStrike, Vicor, and American Airlines and Encourages Investors to Contact the Firm August 26, 2024 From Bragar Eagel & Squire Via GlobeNewswire MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline August 26, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Performance YTD -65.91% -65.91% 1 Month -33.90% -33.90% 3 Month -18.16% -18.16% 6 Month -80.66% -80.66% 1 Year -29.18% -29.18% More News Read More MGNX INVETOR ALERT: Kirby McInerney LLP Reminds MacroGenics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit August 23, 2024 From Kirby McInerney LLP Via GlobeNewswire Evaluating Macrogenics: Insights From 8 Financial Analysts August 15, 2024 Via Benzinga ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX August 21, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm August 20, 2024 From Bragar Eagel & Squire Via GlobeNewswire Robbins LLP Reminds MacroGenics, Inc. (MGNXX) Investors of the Class Action Lawsuit and Pending Lead Plaintiff Deadline August 20, 2024 From Robbins LLP Via GlobeNewswire MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm August 20, 2024 From Schall Law Via GlobeNewswire Kirby McInerney LLP Reminds MacroGenics, Inc. (MGNX) Investors of Class Action Filing and Encourages Investors to Contact the Firm August 19, 2024 From Kirby McInerney LLP Via Business Wire MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline August 19, 2024 From Bernstein Liebhard LLP Via GlobeNewswire TOP RANKED ROSEN LAW FIRM Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX August 18, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC, CrowdStrike, MacroGenics, and Five Below and Encourages Investors to Contact the Firm August 16, 2024 From Bragar Eagel & Squire Via GlobeNewswire MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm August 14, 2024 From Schall Law Via GlobeNewswire Shareholder Rights Law Firm Robbins LLP Urges MGNX Stockholders to Contact the Firm for More Information About the MacroGenics, Inc. Class Action August 12, 2024 From Robbins LLP Via Business Wire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC, CrowdStrike, MacroGenics, and Five Below and Encourages Investors to Contact the Firm August 12, 2024 From Bragar Eagel & Squire Via GlobeNewswire MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline August 12, 2024 From Bernstein Liebhard LLP Via GlobeNewswire MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! August 11, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ROSEN, A LEADING NATIONAL FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX August 09, 2024 From The Rosen Law Firm PA Via GlobeNewswire Kirby McInerney LLP Reminds MacroGenics, Inc. (MGNX) Investors of Class Action Filing and Encourages Investors to Contact the Firm August 07, 2024 From Kirby McInerney LLP Via GlobeNewswire MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX August 07, 2024 From Robbins LLP Via GlobeNewswire MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm August 07, 2024 From Schall Law Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor, American Airlines, and MacroGenics and Encourages Investors to Contact the Firm August 06, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX August 06, 2024 From The Rosen Law Firm PA Via GlobeNewswire MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline August 05, 2024 From Bernstein Liebhard LLP Via GlobeNewswire MGNX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit August 04, 2024 From Robbins Geller Rudman & Dowd LLP Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
